Huadong Medicine Co Stock Price To Earnings To Growth
| 000963 Stock | 35.95 0.24 0.66% |
Huadong Medicine Co fundamentals help investors to digest information that contributes to Huadong Medicine's financial success or failures. It also enables traders to predict the movement of Huadong Stock. The fundamental analysis module provides a way to measure Huadong Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Huadong Medicine stock.
Huadong | Price To Earnings To Growth |
Huadong Medicine Co Company Price To Earnings To Growth Analysis
Huadong Medicine's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Huadong Medicine Co has a Price To Earnings To Growth of 0.0 times. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).
Huadong Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Huadong Medicine's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Huadong Medicine could also be used in its relative valuation, which is a method of valuing Huadong Medicine by comparing valuation metrics of similar companies.Huadong Medicine is currently under evaluation in price to earnings to growth category among its peers.
Huadong Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0671 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 60.7 B | ||||
| Shares Outstanding | 1.75 B | ||||
| Shares Owned By Insiders | 58.08 % | ||||
| Shares Owned By Institutions | 9.87 % | ||||
| Price To Book | 2.86 X | ||||
| Price To Sales | 1.49 X | ||||
| Revenue | 40.62 B | ||||
| Gross Profit | 12.03 B | ||||
| EBITDA | 4.62 B | ||||
| Net Income | 2.84 B | ||||
| Total Debt | 822.38 M | ||||
| Book Value Per Share | 12.64 X | ||||
| Cash Flow From Operations | 3.93 B | ||||
| Earnings Per Share | 1.83 X | ||||
| Target Price | 42.99 | ||||
| Number Of Employees | 16.97 K | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 62.26 B | ||||
| Total Asset | 33.51 B | ||||
| Retained Earnings | 15.69 B | ||||
| Working Capital | 7.69 B | ||||
| Annual Yield | 0.03 % | ||||
| Net Asset | 33.51 B | ||||
| Last Dividend Paid | 0.93 |
About Huadong Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Huadong Medicine Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Huadong Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Huadong Medicine Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Huadong Stock
Huadong Medicine financial ratios help investors to determine whether Huadong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huadong with respect to the benefits of owning Huadong Medicine security.